Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients

被引：0

作者：

Kalpadakis, Christina H.

Pangalis, Gerassimos ^{[2
]}

Vassilakopoulos, Theodoros P. ^{[2
]}

Sachanas, Sotirios P. ^{[3
]}

Kontopidou, Flora

Yiakoumis, Xanthi ^{[3
]}

Kokoris, Styliani

Dimitriadou, Evangelia

Dimopoulou, Maria ^{[5
]}

Moschogiannis, Maria ^{[3
]}

Korkolopoulou, Penelope

Kyrtsonis, Marie-Christine ^{[4
]}

Siakantaris, Marina ^{[6
]}

Papadaki, Helen A. ^{[1
]}

Angelopoulou, Maria K. ^{[2
]}

机构：

[1] Univ Crete, Sch Med, Dept Hematol, Iraklion, Greece

[2] Univ Athens, Dept Hematol, Laikon Gen Hosp, Athens 11528, Greece

[3] Athens Med Ctr, Athens, Greece

[4] Univ Athens, Sch Med, Dept Propedeut & Internal Med 1, GR-11527 Athens, Greece

[5] Laikon Gen Hosp, Thalassemia Ctr, Athens, Greece

[6] Univ Athens, Dept Internal Med 1, Hematol Unit, Laikon Gen Hosp, Athens 11528, Greece

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1167 / 1167

页数：1

共 50 条

[1] Rituximab monotherapy in splenic marginal zone lymphoma
Bennett, M.
Dave, H. P.
Dann, E. J.
Yegena, S.
Chubar, E.
Schechter, G. P.
ANNALS OF ONCOLOGY, 2008, 19 : 228 - 228
[2] Rituximab monotherapy for splenic marginal zone lymphoma
Bennett, Michael
Sharma, Kumud
Yegena, Shaiy
Gavish, Israel
Dave, Harish P.
Schechter, Geraldine P.
HAEMATOLOGICA, 2005, 90 (06) : 856 - 858
[3] Rituximab monotherapy is the treatment of choice of splenic marginal zone lymphoma (SMZL)
Kalpadakis, C.
Pangalis, G. A.
Vassilakopoulos, T. P.
Dimopoulou, M. N.
Kyrtsonis, M.
Korkolopoulou, P.
Kontopidou, F.
Siakantaris, M.
Dimitriadou, E.
Panayiotidis, P.
Papadaki, H.
Angelopoulou, M.
ANNALS OF ONCOLOGY, 2008, 19 : 191 - 191
[4] Rituximab monotherapy in splenic marginal zone lymphoma instead of splenectomy
Bennett, M.
Yegena, S.
Chubar, E.
Schechter, G. P.
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 45 - 45
[5] Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
Bennett, Michael
Yegena, Shaiy
Dave, Harish P.
Schechter, Geraldine P.
HEMATOLOGICAL ONCOLOGY, 2008, 26 (02) : 114 - 114
[6] Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
Kalpadakis, C.
Pangalis, G. A.
Dimopoulou, M. N.
Vassilakopoulos, T. P.
Kyrtsonis, M-C
Korkolopoulou, P.
Kontopidou, F. N.
Siakantaris, M. P.
Dimitriadou, E. M.
Kokoris, S. I.
Tsaftaridis, P.
Plata, E.
Angelopoulou, M. K.
HEMATOLOGICAL ONCOLOGY, 2007, 25 (03) : 127 - 131
[7] Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy
Kalpadakis, Christina
Pangalis, Gerassimos A.
Angelopoulou, Maria K.
Sachanas, Sotirios
Kontopidou, Flora N.
Yiakoumis, Xanthi
Kokoris, Stella I.
Dimitriadou, Evagelia M.
Dimopoulou, Maria N.
Moschogiannis, Maria
Korkolopoulou, Penelope
Kyrtsonis, Marie-Christine
Siakantaris, Marina P.
Papadaki, Theodora
Tsaftaridis, Panayiotis
Plata, Eleni
Papadaki, Helen E.
Vassilakopoulos, Theodoros P.
ONCOLOGIST, 2013, 18 (02): : 190 - 197
[8] TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA (SMZL) IN A SERIES OF 78 PATIENTS: FROM WATCH AND WAIT TO RITUXIMAB MONOTHERAPY
Kalpadakis, C.
Pangalis, G. A.
Vassilakopoulos, T. P.
Dimopoulou, M. N.
Kyrtsonis, M. C.
Korkolopoulou, P.
Korkolopoulou, P.
Kontopidou, F. N.
Siakantaris, M. P.
Dimitriadou, E. M.
Kokoris, S. I.
Sahanas, S.
Dimitrakopoulos, S.
Papadaki, H. A.
Panayiotidis, P.
Angelopoulou, M. K.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 558 - 558
[9] Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life
Mulas, Olga
Caocci, Giovanni
Dessi, Daniela
Mantovani, Daniela
Moi, Giulia
Cabras, Maria Giuseppina
La Nasa, Giorgio
ACTA HAEMATOLOGICA, 2021, 144 (03) : 322 - 326
[10] Role of rituximab in the treatment of splenic marginal zone lymphoma.
Al Shehadat, S
Bast, MA
Sehi, G
Bociek, GR
Kessinger, A
Armitage, JO
BLOOD, 2005, 106 (11) : 253B - 254B

← 1 2 3 4 5 →